EMERYVILLE, Calif.--(BUSINESS WIRE)--Vivani Medical, Inc. (NASDAQ: VANI), an innovative, near-clinical stage biopharmaceutical company that is developing novel, miniature, long-term therapeutic ...
Second Sight, the California-based developer of visual prosthetics and retinal implants, will soon begin a feasibility clinical study to assess its Orion cortical visual prosthesis system in human ...
SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to ...
Second Sight Medical Products Inc. shares traded 25% higher after the company reported the results from a two-year study of its Orion Visual Cortical Prosthesis System. Developer and marketer of ...
Encouraging Interim Results of Orion ® Feasibility Study with Four Subjects Cleared for Home Use LOS ANGELES, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Second Sight Medical Products, Inc. (NASDAQ: EYES) ...
Second Sight Medical Products, Inc. Receives FDA Approval for the Argus 2s Retinal Prosthesis System
LOS ANGELES--(BUSINESS WIRE)-- Second Sight Medical Products (NASDAQ:EYES) a leading developer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful ...
INDIANA, PA, UNITED STATES, November 2, 2022 /EINPresswire.com/ -- Inner Psychophysics IP LLC reports on a research publication describing completion of several steps ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback